Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time off Systemic Therapy in Selected Patients: Data from a Multi-institutional Retrospective Study

Grace Lee, Daniel W. Kim, Oluwadamilola T. Oladeru, Andrzej Niemierko, Kimberly R. Gergelis, Michael G. Haddock, Diego A.S. Toesca, Amanda J. Koong, Dawn Owen, Colin Weekes, Theodore S. Hong, Daniel T. Chang, Christopher L. Hallemeier, Jennifer Y. Wo

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives We evaluated the outcomes of metastatic pancreatic cancer (MPC) patients who underwent liver metastases (LMs)-directed ablative radiotherapy (RT) and sought to characterize patients with more favorable prognosis. Methods A retrospective analysis of 76 MPC patients who underwent ablative RT (median dose, 50 Gy) to LM at 3 academic centers between 2008 and 2018 was performed. Endpoints were local control (LC), progression-free survival, and overall survival (OS) since RT. Results Median follow-up was 10.9 months. Liver metastases were metachronous in 68%. Before RT, LM was responsive/stable on chemotherapy (CTX) in 36% whereas progressive in 43%. Median carbohydrate antigen 19-9 (CA 19-9) at RT was 334 U/mL. After RT, 32% had ≥6 months of CTX break. Twelve-month outcomes were: LC, 66%; progression-free survival, 7%; and OS, 38%. On multivariable analysis, Eastern Cooperative Oncology Group 2-3 (hazard ratio [HR], 13.49; P < 0.01), progressive LM on CTX (HR, 3.26; P < 0.01), and higher CA 19-9 (log10 scale; HR, 1.39; P < 0.01) at RT predicted worse OS. Conclusions Ablative RT to LM in setting of MPC may offer LC of systemic disease and thus quality time off CTX. Selected patients with good performance status, stable/responsive LM on CTX, and lower CA 19-9 have more favorable prognosis.

Original languageEnglish (US)
Pages (from-to)736-743
Number of pages8
JournalPancreas
Volume50
Issue number5
DOIs
StatePublished - 2021

Keywords

  • chemotherapy
  • liver metastasis
  • metastatic
  • pancreatic cancer
  • radiotherapy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

Fingerprint

Dive into the research topics of 'Liver Metastasis-Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time off Systemic Therapy in Selected Patients: Data from a Multi-institutional Retrospective Study'. Together they form a unique fingerprint.

Cite this